查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球醫療第二意見市場
市場調查報告書
商品編碼
1272771

2023-2030 年全球醫療第二意見市場

Global Medical Second Opinion Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球醫療第二意見市場預計到 2022 年將達到 43.448 億美元，到 2030 年將達到 127.018 億美元。 預計醫療第二意見市場在預測期內（2023-2030 年）的複合年增長率為 14.8%。 市場上的遠程醫療趨勢正在推動醫療第二意見市場的增長。

人們通過與醫生的電話交談來使用醫療第二意見服務，消除了患者和醫生之間實際存在的需要以進行治療。 在巴西等國家/地區，遠程醫療正在幫助填補醫療保健方面的空白，使醫生能夠監控患者的需求並快速解決治療延誤問題。

第二醫療意見可用於確認或更改其他醫生推薦的治療策略。 第二醫療意見會對診斷、治療政策和預後產生重大影響。 通過優化治療策略，患者可以避免不必要的風險。 醫生也較少受到法律索賠，醫療保健組織受益於改進的護理、質量控制以及從不必要的手術和治療中節省的成本。

但是，不慎使用該技術可能會導致不合理的醫療費用。 預計在預測期內，擴大癌症和神經系統疾病新興市場、技術進步和市場開發等因素將推動全球醫療第二意見市場的增長。

市場動態

神經系統疾病發病率上升推動醫療第二意見市場的增長

在世界許多地方，包括美國，神經系統疾病是一個嚴重的問題，並且其數量正在增加。 不幸的是，許多人對神經系統疾病、什麼是神經系統疾病以及它們如何影響神經系統疾病患者的整體生活質量沒有正確的認識。 由於此類疑難神經系統疾病的增加，市場正在蓬勃發展。

例如，根據 Classic Rehabilitation, Inc. 的數據，全世界每年有近 700 萬人死於神經系統疾病，超過 10 億人受到一種或多種神經系統疾病的影響。 因此，疾病正在增加，促使市場擴張。

缺乏認識阻礙了全球醫療第二意見市場的增長

然而，在發展中國家，目前的情況是缺乏尋求醫學第二意見的知識和意願。 大多數人認為醫生的在線第二意見僅適用於嚴重的醫療情況。 預計這將阻礙市場增長。

COVID-19 影響分析

醫療第二意見的全球市場受益於 COVID-19，隨著大流行的蔓延推動進一步增長。 由於大多數人都有涵蓋醫療保健的健康保險，而且設施目前已滿負荷運轉，因此可能無法獲得足夠優質的護理。 在這種情況下，第二醫療意見確實可以幫助和協助市場。 在市場上提供的各種治療方法中做出決定可能很困難。 為患者提供第二醫療意見以獲得最有效和可靠的治療。

俄烏衝突分析

由於該地區的滲透率低且缺乏主要市場參與者，因此估計俄羅斯-烏克蘭對全球醫療第二意見市場的影響較小。 然而，原材料、試驗產品和設備進出口的影響預計在預測期內對全球醫療第二意見市場影響不大。

人工智能影響分析

人工智能有望對全球醫療第二意見市場產生積極影響。 人工智能（AI）輔助診療規劃應該有第二意見的權利，但這種權利不應該一定被解釋為醫生意見的權利。 另一個獨立的人工智能係統或許能夠滿足第二意見的需要。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 無序片段
  • 按服務類型
  • 區域摘要

第四章市場動態

  • 影響因素
    • 主持人
      • 保護患者免於誤診
      • 神經系統疾病的發病率增加
    • 約束因素
      • 第二意見的高成本阻礙了市場擴張
    • 機會
      • 有利的政府政策為主要參與者創造商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第七章俄烏衝突分析

第8章人工智能的影響分析

第9章疾病

  • 癌症
  • 糖尿病
  • 心髒病
  • 神經系統疾病
  • 眼科疾病
  • 其他

第 10 章按服務類型

  • 醫院
  • 醫療第二意見提供者
  • 健康保險公司

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 競爭場景
  • 市場份額分析
  • 併購分析

第13章公司簡介

  • Mediguide International LLC。
    • 公司概況
    • 產品組合和說明
    • 財務摘要
    • 主要發展狀況
  • WorldCare Inc.
  • Cynergy Care
  • AXA PPP Healthcare
  • Cleveland Clinic
  • Helsana Group
  • Teladoc Health
  • GrandOpinion
  • Lybrate
  • Mass General Brigham

第14章 附錄

簡介目錄
Product Code: HCIT2076

Market Overview

The global medical second opinion market reached US$ 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 12,701.8 million by 2030. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period (2023-2030). The telemedicine trend in the market is driving the growth of the medical second opinion market.

People are using medical second opinion services through telephonic conversation with their doctors, which also eliminates the physical presence of patients and their doctors for their treatment. In countries like Brazil, telemedicine is helping to fill the healthcare gaps, allowing physicians to monitor patients' needs and eliminate treatment delays quickly.

A second medical opinion can be used to confirm or change a recommended course of therapy made by another doctor. A second medical opinion may have a significant impact on the diagnosis, course of treatment, and prognosis. By optimizing the course of treatment, the patient can avoid unneeded hazards. Less exposure to legal claims benefits doctors, while improved care, quality control, and cost savings from unneeded surgeries and treatments benefit healthcare organisations.

However, using this technology carelessly can result in irrational medical expenses. The factors such as growing cases of cancer, neurological disorders, technological advancements, and market developments are expected to boost the global medical second opinion market growth over the forecast period.

Market Dynamics

Increased incidence of neurological disorders is driving the medical second opinion market growth

In many parts of the world, including in the U.S., neurological illnesses are a severe and growing problem. Unfortunately, a lot of people do not properly comprehend neurological illnesses, including what they are and how they affect the overall quality of life for those who are affected. The market is fueled in part by the rise in neurological illnesses.

For instance, according to Classic Rehabilitation, Inc., almost 7 million individuals worldwide pass away each year as a result of a neurological ailment, and more than 1 billion people are affected by one or more neurological diseases. As a result, diseases are on the rise, which stimulates market expansion.

The lack of awareness will hamper the global medical second opinion market growth

However, in developing countries, there is a lack of knowledge and desire to seek a second medical opinion. Most people believe that online second opinions from doctors are only for serious medical situations. This is expected to hamper the market growth.

COVID-19 Impact Analysis

The global market for medical second opinions has benefited from COVID-19, which further encouraged growth as the pandemic spread. There may not be enough high-quality therapies accessible because the majority of people have health insurance that covers their care and the facilities are currently at capacity. In these cases, a second medical opinion is really helpful and assists the market. Making a decision among the wide range of treatments offered on the market is challenging. To receive the best care with the greatest effectiveness and dependability, the patient may use a second medical opinion.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global medical second opinion market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global medical second opinion market over the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact positively for the global medical second opinion market. There should be a right to a second opinion for diagnosis and treatment planning aided by artificial intelligence (AI), but this right should not always be interpreted as a right to a physician's view. Another independent AI system may be able to satisfy the need for a second opinion.

Segment Analysis

The global medical second opinionmarket is segmented based on disorder, service provider, and region.

The medical second opinion providing companies segment is estimated to hold a majority of the medical second opinion market share during the forecast period

The medical second opinion providing companies segment holds about 33.2% market share of the total medical second opinion market. Medical second opinion providing companies segment growth is driven by the companies that offer risk-free services to patients and provide medical second opinions. For instance, online second opinions from medical second opinion providers offer patients a quick, easy, and secure option to acquire responses to their inquiries concerning a diagnosis or course of therapy.

People can contact with a knowledgeable doctor who specializes in their particular medical requirements through an online second opinion programme. Additionally, the segment is also driven by corporate initiatives including partnerships and acquisitions.

For instance, on January 14, 2021, Accolade, Inc., a company that offers individualized, tech-enabled solutions to help people better understand, navigate, and use the healthcare system and their workplace benefits, announced that it entered into a legally binding agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD), a prominent provider of expert medical advice and medical decision support services with headquarters in Houston, Texas.

Geographical Analysis

North America is estimated to hold the largest share of the global medical second opinion market during the forecast period

The North America region holds the largest share of the global medical second opinion market accounting for approximately 39.4% over the forecast period.

The use of telemedicine technologies enables communication between doctors and patients across geographic borders. During the forecast period, the market for medical second opinions is anticipated to benefit greatly from the considerable advantages of telemedicine technology and rising investments.

For instance, TeleHealth Solution (THS) received funding in March 2020 from innovative Capital Partners (NCP), a private equity company in Birmingham, Alabama, to create innovative telemedicine technology. Nursing services, long-term care, and assisted living facilities will benefit greatly from these new technology. In order to make healthcare more easily accessible to a broad number of individuals, the firm plans to establish pre-consultations, second medical opinions, and appointment-booking systems with the aid of this financing.

Competitive Landscape

The major global players in the market include Mediguide International LLC, WorldCare Inc, Cynergy Care, AXA PPP Healthcare, Cleveland Clinic, Helsana Group, Teladoc Health, GrandOpinion, and Lybrate, among others.

Why Purchase the Report?

  • To visualize the global medical second opinion market segmentation based on disorder, service provider, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of medical second opinion market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global medical second opinion market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Disorder
  • 3.2. Snippet by Service Type
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Safeguarding patients from misdiagnosis
      • 4.1.1.2. Increased Incidences of Neurological Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. The market's expansion is being hampered by the high cost of medical second opinions
    • 4.1.3. Opportunity
      • 4.1.3.1. Favorable government policies will create an opportunities for key players
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine Conflict Analysis

8. Artificial Intelligence Impact Analysis

9. By Disorder

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 9.1.2. Market Attractiveness Index, By Disorder
  • 9.2. Cancer
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diabetes
  • 9.4. Cardiac Disorders
  • 9.5. Neurological Disorders
  • 9.6. Ocular Disorders
  • 9.7. Others

10. By Service Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.1.2. Market Attractiveness Index, By Service Type
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Medical Second Opinion Providing Companies
  • 10.4. Health Insurance Companies

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.5.1. The U.S.
      • 11.2.5.2. Canada
      • 11.2.5.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.5.1. Germany
      • 11.3.5.2. The U.K.
      • 11.3.5.3. France
      • 11.3.5.4. Italy
      • 11.3.5.5. Spain
      • 11.3.5.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.5.1. Brazil
      • 11.4.5.2. Argentina
      • 11.4.5.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.5.1. China
      • 11.5.5.2. India
      • 11.5.5.3. Japan
      • 11.5.5.4. Australia
      • 11.5.5.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Mediguide International LLC.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. WorldCare Inc.
  • 13.3. Cynergy Care
  • 13.4. AXA PPP Healthcare
  • 13.5. Cleveland Clinic
  • 13.6. Helsana Group
  • 13.7. Teladoc Health
  • 13.8. GrandOpinion
  • 13.9. Lybrate
  • 13.10. Mass General Brigham

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us